Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07122843) titled 'VR AI Meditation for Pain' on Aug. 8.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Christopher Almario
Condition:
Pain and Anxiety
Intervention:
Device: VR Guided Meditation
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: September 20, 2025
Target Sample Size: 38
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/ct2/show/NCT07122843
Published by HT Digital Content Services with permission from Health Daily Diges...